| Year |
Citation |
Score |
| 2021 |
Kryštůfek R, Šácha P, Starková J, Brynda J, Hradilek M, Tloušt'ová E, Grzymska J, Rut W, Boucher MJ, Drąg M, Majer P, Hájek M, Řezáčová P, Madhani HD, Craik CS, ... Konvalinka J, et al. Re-emerging Aspartic Protease Targets: Examining Major Aspartyl Peptidase 1 as a Target for Antifungal Drug Discovery. Journal of Medicinal Chemistry. 64: 6706-6719. PMID 34006103 DOI: 10.1021/acs.jmedchem.0c02177 |
0.305 |
|
| 2019 |
Majerová T, Novotný P, Krýsová E, Konvalinka J. Exploiting the unique features of Zika and Dengue proteases for inhibitor design. Biochimie. 166: 132-141. PMID 31077760 DOI: 10.1016/j.biochi.2019.05.004 |
0.343 |
|
| 2019 |
Vorlova B, Knedlik T, Tykvart J, Konvalinka J. GCPII and its close homolog GCPIII: from a neuropeptidase to a cancer marker and beyond. Frontiers in Bioscience (Landmark Edition). 24: 648-687. PMID 30844704 |
0.303 |
|
| 2018 |
Humpolíčková J, Weber J, Starková J, Mašínová E, Günterová J, Flaisigová I, Konvalinka J, Majerová T. Inhibition of the precursor and mature forms of HIV-1 protease as a tool for drug evaluation. Scientific Reports. 8: 10438. PMID 29992979 DOI: 10.1038/s41598-018-28638-w |
0.34 |
|
| 2017 |
Tretyachenko V, Vymětal J, Bednárová L, Kopecký V, Hofbauerová K, Jindrová H, Hubálek M, Souček R, Konvalinka J, Vondrášek J, Hlouchová K. Random protein sequences can form defined secondary structures and are well-tolerated in vivo. Scientific Reports. 7: 15449. PMID 29133927 DOI: 10.1038/s41598-017-15635-8 |
0.682 |
|
| 2017 |
Knedlík T, Vorlová B, Navrátil V, Tykvart J, Sedlák F, Vaculín Š, Franěk M, Šácha P, Konvalinka J. Mouse glutamate carboxypeptidase II (GCPII) has a similar enzyme activity and inhibition profile but a different tissue distribution to human GCPII. Febs Open Bio. 7: 1362-1378. PMID 28904865 DOI: 10.1002/2211-5463.12276 |
0.312 |
|
| 2016 |
Hanne J, Göttfert F, Schimer J, Anders-Össwein M, Konvalinka J, Engelhardt J, Müller B, Hell SW, Kräusslich HG. Stimulated Emission Depletion Nanoscopy Reveals Time-Course of Human Immunodeficiency Virus Proteolytic Maturation. Acs Nano. PMID 27517329 DOI: 10.1021/Acsnano.6B03850 |
0.566 |
|
| 2016 |
Albiñana CB, Machara A, Řezáčová P, Pachl P, Konvalinka J, Kožíšek M. Kinetic, thermodynamic and structural analysis of tamiphosphor binding to neuraminidase of H1N1 (2009) pandemic influenza. European Journal of Medicinal Chemistry. 121: 100-109. PMID 27236066 DOI: 10.1016/J.Ejmech.2016.05.016 |
0.3 |
|
| 2016 |
Navrátil M, Tykvart J, Schimer J, Pachl P, Navrátil V, Rokob TA, Hlouchová K, Rulíšek L, Konvalinka J. Comparison of human glutamate carboxypeptidases II and III reveals their divergent substrate specificities. The Febs Journal. PMID 27208881 DOI: 10.1111/Febs.13761 |
0.745 |
|
| 2015 |
Tykvart J, Schimer J, Jančařík A, Bařinková J, Navrátil V, Starková J, Šrámková K, Konvalinka J, Majer P, Šácha P. Design of highly potent urea-based, exosite-binding inhibitors selective for glutamate carboxypeptidase II. Journal of Medicinal Chemistry. 58: 4357-63. PMID 25923815 DOI: 10.1021/acs.jmedchem.5b00278 |
0.357 |
|
| 2015 |
Konvalinka J, Kräusslich HG, Müller B. Retroviral proteases and their roles in virion maturation. Virology. 479: 403-17. PMID 25816761 DOI: 10.1016/j.virol.2015.03.021 |
0.611 |
|
| 2015 |
Tykvart J, Bařinka C, Svoboda M, Navrátil V, Souček R, Hubálek M, Hradilek M, Šácha P, Lubkowski J, Konvalinka J. Structural and biochemical characterization of a novel aminopeptidase from human intestine. The Journal of Biological Chemistry. 290: 11321-36. PMID 25752612 DOI: 10.1074/jbc.M114.628149 |
0.323 |
|
| 2015 |
Schimer J, Pávová M, Anders M, Pachl P, Šácha P, Cígler P, Weber J, Majer P, ?ezá?ová P, Kräusslich HG, Müller B, Konvalinka J. Triggering HIV polyprotein processing by light using rapid photodegradation of a tight-binding protease inhibitor. Nature Communications. 6: 6461. PMID 25751579 DOI: 10.1038/ncomms7461 |
0.58 |
|
| 2015 |
Vorlová B, Nachtigallová D, Jirásková-Vaníčková J, Ajani H, Jansa P, Rezáč J, Fanfrlík J, Otyepka M, Hobza P, Konvalinka J, Lepšík M. Malonate-based inhibitors of mammalian serine racemase: kinetic characterization and structure-based computational study. European Journal of Medicinal Chemistry. 89: 189-97. PMID 25462239 DOI: 10.1016/J.Ejmech.2014.10.043 |
0.33 |
|
| 2014 |
Mattei S, Anders M, Konvalinka J, Kräusslich HG, Briggs JA, Müller B. Induced maturation of human immunodeficiency virus. Journal of Virology. 88: 13722-31. PMID 25231305 DOI: 10.1128/JVI.02271-14 |
0.568 |
|
| 2014 |
Tykvart J, Schimer J, Bařinková J, Pachl P, Poštová-Slavětínská L, Majer P, Konvalinka J, Šácha P. Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery. Bioorganic & Medicinal Chemistry. 22: 4099-108. PMID 24954515 DOI: 10.1016/j.bmc.2014.05.061 |
0.305 |
|
| 2014 |
Navrátil M, Ptáček J, Šácha P, Starková J, Lubkowski J, Bařinka C, Konvalinka J. Structural and biochemical characterization of the folyl-poly-γ-l-glutamate hydrolyzing activity of human glutamate carboxypeptidase II. The Febs Journal. 281: 3228-42. PMID 24863754 DOI: 10.1111/febs.12857 |
0.357 |
|
| 2014 |
Grantz Šašková K, Kozíšek M, Stray K, de Jong D, Rezáová P, Brynda J, van Maarseveen NM, Nijhuis M, Cihlár T, Konvalinka J. GS-8374, a prototype phosphonate-containing inhibitor of HIV-1 protease, effectively inhibits protease mutants with amino acid insertions. Journal of Virology. 88: 3586-90. PMID 24371077 DOI: 10.1128/JVI.02688-13 |
0.328 |
|
| 2013 |
Pokorná J, Heyda J, Konvalinka J. Ion specific effects of alkali cations on the catalytic activity of HIV-1 protease. Faraday Discussions. 160: 359-70; discussion 3. PMID 23795510 DOI: 10.1039/C2Fd20094E |
0.323 |
|
| 2012 |
Schimer J, Cígler P, Veselý J, Grantz Šašková K, Lepšík M, Brynda J, Rezáčová P, Kožíšek M, Císařová I, Oberwinkler H, Kraeusslich HG, Konvalinka J. Structure-aided design of novel inhibitors of HIV protease based on a benzodiazepine scaffold. Journal of Medicinal Chemistry. 55: 10130-5. PMID 23050738 DOI: 10.1021/jm301249q |
0.3 |
|
| 2012 |
KozÃsek M, Henke S, Sasková KG, Jacobs GB, Schuch A, Buchholz B, Müller V, Kräusslich HG, Rezácová P, Konvalinka J, Bodem J. Mutations in HIV-1 gag and pol compensate for the loss of viral fitness caused by a highly mutated protease. Antimicrobial Agents and Chemotherapy. 56: 4320-30. PMID 22644035 DOI: 10.1128/AAC.00465-12 |
0.581 |
|
| 2011 |
Plechanovová A, Byun Y, Alquicer G, Skultétyová L, Mlčochová P, Němcová A, Kim HJ, Navrátil M, Mease R, Lubkowski J, Pomper M, Konvalinka J, Rulíšek L, Bařinka C. Novel substrate-based inhibitors of human glutamate carboxypeptidase II with enhanced lipophilicity. Journal of Medicinal Chemistry. 54: 7535-46. PMID 21923190 DOI: 10.1021/Jm200807M |
0.358 |
|
| 2011 |
Fun A, van Maarseveen NM, Pokorná J, Maas RE, Schipper PJ, Konvalinka J, Nijhuis M. HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat. Retrovirology. 8: 70. PMID 21864346 DOI: 10.1186/1742-4690-8-70 |
0.314 |
|
| 2011 |
Jirásková-Vaníčková J, Ettrich R, Vorlová B, Hoffman HE, Lepšík M, Jansa P, Konvalinka J. Inhibition of human serine racemase, an emerging target for medicinal chemistry. Current Drug Targets. 12: 1037-55. PMID 21291385 |
0.305 |
|
| 2010 |
Hoffman HE, Jirásková J, Zvelebil M, Konvalinka J. Random mutagenesis of human serine racemase reveals residues important for the enzymatic activity Collection of Czechoslovak Chemical Communications. 75: 59-79. DOI: 10.1135/CCCC2010003 |
0.345 |
|
| 2009 |
Rezácová P, Pokorná J, Brynda J, Kozísek M, Cígler P, Lepsík M, Fanfrlík J, Rezác J, Grantz Sasková K, Sieglová I, Plesek J, Sícha V, Grüner B, Oberwinkler H, Sedlácek' J, ... ... Konvalinka J, et al. Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranes. Journal of Medicinal Chemistry. 52: 7132-41. PMID 19874035 DOI: 10.1021/Jm9011388 |
0.557 |
|
| 2009 |
Hoffman HE, Jirásková J, Cígler P, Sanda M, Schraml J, Konvalinka J. Hydroxamic acids as a novel family of serine racemase inhibitors: mechanistic analysis reveals different modes of interaction with the pyridoxal-5'-phosphate cofactor. Journal of Medicinal Chemistry. 52: 6032-41. PMID 19791805 DOI: 10.1021/jm900775q |
0.34 |
|
| 2009 |
Hlouchova K, Barinka C, Konvalinka J, Lubkowski J. Structural insight into the evolutionary and pharmacologic homology of glutamate carboxypeptidases II and III. The Febs Journal. 276: 4448-62. PMID 19678840 DOI: 10.1111/j.1742-4658.2009.07152.x |
0.754 |
|
| 2009 |
Sasková KG, Kozísek M, Rezácová P, Brynda J, Yashina T, Kagan RM, Konvalinka J. Molecular characterization of clinical isolates of human immunodeficiency virus resistant to the protease inhibitor darunavir. Journal of Virology. 83: 8810-8. PMID 19535439 DOI: 10.1128/JVI.00451-09 |
0.335 |
|
| 2009 |
Klusak V, Barinka C, Plechanovova A, Mlcochova P, Konvalinka J, Rulisek L, Lubkowski J. Reaction mechanism of glutamate carboxypeptidase II revealed by mutagenesis, X-ray crystallography, and computational methods. Biochemistry. 48: 4126-4138. PMID 19301871 DOI: 10.1021/Bi900220S |
0.334 |
|
| 2008 |
Kozísek M, Sasková KG, Rezácová P, Brynda J, van Maarseveen NM, De Jong D, Boucher CA, Kagan RM, Nijhuis M, Konvalinka J. Ninety-nine is not enough: molecular characterization of inhibitor-resistant human immunodeficiency virus type 1 protease mutants with insertions in the flap region. Journal of Virology. 82: 5869-78. PMID 18400858 DOI: 10.1128/Jvi.02325-07 |
0.344 |
|
| 2008 |
Barinka C, Hlouchova K, Rovenska M, Majer P, Dauter M, Hin N, Ko YS, Tsukamoto T, Slusher BS, Konvalinka J, Lubkowski J. Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs. Journal of Molecular Biology. 376: 1438-50. PMID 18234225 DOI: 10.1016/j.jmb.2007.12.066 |
0.751 |
|
| 2008 |
Rovenská M, Hlouchová K, Sácha P, Mlcochová P, Horák V, Zámecník J, Barinka C, Konvalinka J. Tissue expression and enzymologic characterization of human prostate specific membrane antigen and its rat and pig orthologs. The Prostate. 68: 171-82. PMID 18076021 DOI: 10.1002/pros.20676 |
0.695 |
|
| 2007 |
Kozísek M, Bray J, Rezácová P, Sasková K, Brynda J, Pokorná J, Mammano F, Rulísek L, Konvalinka J. Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants. Journal of Molecular Biology. 374: 1005-16. PMID 17977555 DOI: 10.1016/j.jmb.2007.09.083 |
0.325 |
|
| 2007 |
Mlcochová P, Plechanovová A, Barinka C, Mahadevan D, Saldanha JW, Rulísek L, Konvalinka J. Mapping of the active site of glutamate carboxypeptidase II by site-directed mutagenesis. The Febs Journal. 274: 4731-41. PMID 17714508 DOI: 10.1111/J.1742-4658.2007.06021.X |
0.413 |
|
| 2007 |
Barinka C, Rovenská M, Mlcochová P, Hlouchová K, Plechanovová A, Majer P, Tsukamoto T, Slusher BS, Konvalinka J, Lubkowski J. Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II. Journal of Medicinal Chemistry. 50: 3267-73. PMID 17567119 DOI: 10.1021/jm070133w |
0.749 |
|
| 2007 |
Nijhuis M, van Maarseveen NM, Lastere S, Schipper P, Coakley E, Glass B, Rovenska M, de Jong D, Chappey C, Goedegebuure IW, Heilek-Snyder G, Dulude D, Cammack N, Brakier-Gingras L, Konvalinka J, et al. A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism. Plos Medicine. 4: e36. PMID 17227139 DOI: 10.1371/Journal.Pmed.0040036 |
0.55 |
|
| 2006 |
Hlouchová K, Bařinka C, Klusák V, Šácha P, Mlčochová P, Majer P, Rulíšek L, Konvalinka J. Biochemical characterization of human glutamate carboxypeptidase III. Journal of Neurochemistry. 101: 682-696. PMID 17241121 DOI: 10.1111/J.1471-4159.2006.04341.X |
0.753 |
|
| 2006 |
Skalova T, Dohnalek J, Duskova J, Petrokova H, Hradílek M, Soucek M, Konvalinka J, Hasek J. HIV-1 protease mutations and inhibitor modifications monitored on a series of complexes. Structural basis for the effect of the A71V mutation on the active site. Journal of Medicinal Chemistry. 49: 5777-84. PMID 16970402 DOI: 10.1021/jm0605583 |
0.337 |
|
| 2006 |
Koval D, Jirásková J, Strísovský K, Konvalinka J, Kasicka V. Capillary electrophoresis method for determination of D-serine and its application for monitoring of serine racemase activity. Electrophoresis. 27: 2558-66. PMID 16721908 DOI: 10.1002/elps.200500946 |
0.671 |
|
| 2006 |
Dusková J, Dohnálek J, Skálová T, Petroková H, Vondrácková E, Hradílek M, Konvalinka J, Soucek M, Brynda J, Fábry M, Sedlácek J, Hasek J. On the role of the R configuration of the reaction-intermediate isostere in HIV-1 protease-inhibitor binding: X-ray structure at 2.0 A resolution. Acta Crystallographica. Section D, Biological Crystallography. 62: 489-97. PMID 16627941 DOI: 10.1107/S0907444906006718 |
0.339 |
|
| 2006 |
Mesters JR, Barinka C, Li W, Tsukamoto T, Majer P, Slusher BS, Konvalinka J, Hilgenfeld R. Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer. The Embo Journal. 25: 1375-84. PMID 16467855 DOI: 10.1038/sj.emboj.7600969 |
0.38 |
|
| 2005 |
Cígler P, Kozísek M, Rezácová P, Brynda J, Otwinowski Z, Pokorná J, Plesek J, Grüner B, Dolecková-Maresová L, Mása M, Sedlácek J, Bodem J, Kräusslich HG, Král V, Konvalinka J. From nonpeptide toward noncarbon protease inhibitors: metallacarboranes as specific and potent inhibitors of HIV protease. Proceedings of the National Academy of Sciences of the United States of America. 102: 15394-9. PMID 16227435 DOI: 10.1073/pnas.0507577102 |
0.606 |
|
| 2005 |
Strísovský K, Jirásková J, Mikulová A, Rulísek L, Konvalinka J. Dual substrate and reaction specificity in mouse serine racemase: identification of high-affinity dicarboxylate substrate and inhibitors and analysis of the beta-eliminase activity. Biochemistry. 44: 13091-100. PMID 16185077 DOI: 10.1021/bi051201o |
0.681 |
|
| 2005 |
Caffrey CR, Placha L, Barinka C, Hradilek M, Dostál J, Sajid M, McKerrow JH, Majer P, Konvalinka J, Vondráŝek J. Homology modeling and SAR analysis of Schistosoma japonicum cathepsin D (SjCD) with statin inhibitors identify a unique active site steric barrier with potential for the design of specific inhibitors Biological Chemistry. 386: 339-349. PMID 15899696 DOI: 10.1515/Bc.2005.041 |
0.307 |
|
| 2004 |
Petroková H, Dusková J, Dohnálek J, Skálová T, Vondrácková-Buchtelová E, Soucek M, Konvalinka J, Brynda J, Fábry M, Sedlácek J, Hasek J. Role of hydroxyl group and R/S configuration of isostere in binding properties of HIV-1 protease inhibitors. European Journal of Biochemistry. 271: 4451-61. PMID 15560786 DOI: 10.1111/j.1432-1033.2004.04384.x |
0.326 |
|
| 2004 |
Svec M, Bauerová H, Pichová I, Konvalinka J, Strísovský K. Proteinases of betaretroviruses bind single-stranded nucleic acids through a novel interaction module, the G-patch. Febs Letters. 576: 271-6. PMID 15474050 DOI: 10.1016/j.febslet.2004.09.010 |
0.663 |
|
| 2004 |
Barinka C, Mlcochová P, Sácha P, Hilgert I, Majer P, Slusher BS, Horejsí V, Konvalinka J. Amino acids at the N- and C-termini of human glutamate carboxypeptidase II are required for enzymatic activity and proper folding. European Journal of Biochemistry. 271: 2782-90. PMID 15206943 DOI: 10.1111/j.1432-1033.2004.04209.x |
0.321 |
|
| 2004 |
Barinka C, Sácha P, Sklenár J, Man P, Bezouska K, Slusher BS, Konvalinka J. Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity. Protein Science : a Publication of the Protein Society. 13: 1627-35. PMID 15152093 DOI: 10.1110/ps.04622104 |
0.316 |
|
| 2004 |
Brynda J, Rezacova P, Fabry M, Horejsi M, Stouracova R, Sedlacek J, Soucek M, Hradilek M, Lepsik M, Konvalinka J. A phenylnorstatine inhibitor binding to HIV-1 protease: geometry, protonation, and subsite-pocket interactions analyzed at atomic resolution. Journal of Medicinal Chemistry. 47: 2030-6. PMID 15056001 DOI: 10.1021/jm031105q |
0.313 |
|
| 2004 |
Kožíšek M, Prejdová J, Souček M, Machala L, Staňková M, Linka M, Brůčková M, Konvalinka J. Characterisation of Mutated Proteinases Derived from HIV-Positive Patients: Enzyme Activity, Vitality and Inhibition Collection of Czechoslovak Chemical Communications. 69: 703-714. DOI: 10.1135/CCCC20040703 |
0.316 |
|
| 2003 |
Ingr M, Uhlíková T, Strísovský K, Majerová E, Konvalinka J. Kinetics of the dimerization of retroviral proteases: the "fireman's grip" and dimerization. Protein Science : a Publication of the Protein Society. 12: 2173-82. PMID 14500875 DOI: 10.1110/ps.03171903 |
0.705 |
|
| 2003 |
Strísovský K, Jirásková J, Barinka C, Majer P, Rojas C, Slusher BS, Konvalinka J. Mouse brain serine racemase catalyzes specific elimination of L-serine to pyruvate. Febs Letters. 535: 44-8. PMID 12560076 DOI: 10.1016/s0014-5793(02)03855-3 |
0.691 |
|
| 2002 |
Weber J, Mesters JR, Lepsík M, Prejdová J, Svec M, Sponarová J, Mlcochová P, Skalická K, Strísovský K, Uhlíková T, Soucek M, Machala L, Stanková M, Vondrásek J, Klimkait T, ... ... Konvalinka J, et al. Unusual binding mode of an HIV-1 protease inhibitor explains its potency against multi-drug-resistant virus strains. Journal of Molecular Biology. 324: 739-54. PMID 12460574 |
0.681 |
|
| 2002 |
Dohnálek J, Hasek J, Dusková J, Petroková H, Hradilek M, Soucek M, Konvalinka J, Brynda J, Sedlácek J, Fábry M. Hydroxyethylamine isostere of an HIV-1 protease inhibitor prefers its amine to the hydroxy group in binding to catalytic aspartates. A synchrotron study of HIV-1 protease in complex with a peptidomimetic inhibitor. Journal of Medicinal Chemistry. 45: 1432-8. PMID 11906284 DOI: 10.1021/jm010979e |
0.329 |
|
| 2002 |
Barinka C, Rinnová M, Sácha P, Rojas C, Majer P, Slusher BS, Konvalinka J. Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II. Journal of Neurochemistry. 80: 477-87. PMID 11905994 DOI: 10.1046/j.0022-3042.2001.00715.x |
0.37 |
|
| 2002 |
Strísovský K, Smrz D, Fehrmann F, Kräusslich HG, Konvalinka J. The murine endogenous retrovirus MIA14 encodes an active aspartic proteinase that is functionally similar to proteinases from D-type retroviruses. Archives of Biochemistry and Biophysics. 398: 261-8. PMID 11831858 DOI: 10.1006/abbi.2001.2728 |
0.73 |
|
| 2001 |
Strisovsky K, Tessmer U, Langner J, Konvalinka J, Kräusslich HG. Systematic mutational analysis of the active-site threonine of HIV-1 proteinase: rethinking the "fireman's grip" hypothesis. Protein Science : a Publication of the Protein Society. 9: 1631-41. PMID 11045610 DOI: 10.1110/PS.9.9.1631 |
0.314 |
|
| 1998 |
Konvalinka J, Litera J, Weber J, Vondrásek J, Hradílek M, Soucek M, Pichová I, Majer P, Strop P, Sedlácek J, Heuser AM, Kottler H, Kräusslich HG. Configurations of diastereomeric hydroxyethylene isosteres strongly affect biological activities of a series of specific inhibitors of human-immunodeficiency-virus proteinase. European Journal of Biochemistry. 250: 559-66. PMID 9428710 DOI: 10.1111/J.1432-1033.1997.0559A.X |
0.368 |
|
| 1996 |
Uhlíková T, Konvalinka J, Pichová I, Soucek M, Kräusslich HG, Vondrásek J. A modular approach to HIV-1 proteinase inhibitor design. Biochemical and Biophysical Research Communications. 222: 38-43. PMID 8630071 DOI: 10.1006/BBRC.1996.0694 |
0.318 |
|
| 1995 |
Konvalinka J, Litterst MA, Welker R, Kottler H, Rippmann F, Heuser AM, Kräusslich HG. An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity. Journal of Virology. 69: 7180-6. PMID 7474139 DOI: 10.1128/jvi.69.11.7180-7186.1995 |
0.314 |
|
| 1992 |
Jupp RA, Richards AD, Phylip LH, Kay J, Konvalinka J, Strop P, Kostka V, Scarborough PE, Farmerie WG, Dunn BM. Substrate cleavage by HIV-1 proteinase. Advances in Experimental Medicine and Biology. 306: 461-7. PMID 1812743 DOI: 10.1007/978-1-4684-6012-4_59 |
0.388 |
|
| 1992 |
Griffiths JT, Phylip LH, Konvalinka J, Strop P, Gustchina A, Wlodawer A, Davenport RJ, Briggs R, Dunn BM, Kay J. Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites Biochemistry. 31: 5193-5200. PMID 1606143 DOI: 10.1021/Bi00137A015 |
0.314 |
|
| Show low-probability matches. |